Investigational study provides evidence that recombinant endolysin XZ 700* is a promising novel non-antibiotic treatment strategy aimed at controlling Staphylococcus aureus S aureus colonization of lesional skin in Cutaneous T-cell lymphoma CTCL : vimarsana.com

Investigational study provides evidence that recombinant endolysin XZ 700* is a promising novel non-antibiotic treatment strategy aimed at controlling Staphylococcus aureus S aureus colonization of lesional skin in Cutaneous T-cell lymphoma CTCL

- Research shows XZ.700* could block tumor promoting effects of S. aureus on malignant T cells, potentially delaying tumor progression.
Findings strengthen ...

Related Keywords

Switzerland , , Cutaneoust Cell , Investigational , Tudy , Rovides , Vidence , Hat , Recombinant , Ndolysin , 00 , Romising , Ovel , On , Ntibiotic , Reatment , Trategy , Imed , Ontrolling , Staphylococcus , Laureus , Colonization , Esional , Kin , Cutaneous , Ell , Ymphoma , Tcl ,